Neoprobe Corporation - Innovations in Care... Improvements in Lives

Innovations in Care...

...Improvements in Lives

Home • About Us • Gamma Detection Devices • Blood Flow Measurement • Investigational Initiatives • News & Investors • Contact Us • Site Map

News & Investor Relations


Stock Price

Recent Press Releases

Annual Report and Proxy

Corporate Governance

Corporate Governance

Code of Business Conduct and Ethics

The management and directors of Neoprobe Corporation are commited to the honest and ethical conduct of our business and the full, fair, accurate, timely and understandable disclosure in reports and documents we file with, or submit to, the U.S. Securities and Exchange Commission (SEC) and in other public communications we make. As such, the Board of Directors adopted a Code of Business Conduct and Ethics to deter wrongdoing and promote these principles in the daily conduct of our business. A copy of the Code of Business Conduct and Ethics is available for your review.

Board Committee Charters

Audit Committee Charter

Compensation, Nominating and Governance Committee Charter

All SEC filings

Copies of all of our filings with the SEC, including 1933 Act (registration statements) and 1934 Act (periodic filings) are available by clicking on the following link: (ALL SEC FILINGS)

Section 16 SEC filings (ONLY)

Copies of all Section 16 filings related to securities transactions made by those considered "insiders"are available by clicking on the following link: (SECTION 16 FILINGS)